Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Frances A. Shepherd

Department of Medicine

Division of Medical Oncology and Hematology of the University Health Network

Princess Margaret Hospital and the University of Toronto

Ontario

Canada

[email]@uhn.on.ca

Name/email consistency: high

[Claim this account]

Affiliations

Department of Medicine, Division of Medical Oncology and Hematology of the University Health Network, Princess Margaret Hospital and the University of Toronto, Ontario, Canada. 2007
Princess Margaret Hospital, Toronto, Ontario, Canada. 2000 - 2007
Division of Hematology Oncology, Department of Medicine, University Health Network, Princess Margaret Hospital Division, Canada. 2003
National Cancer Institute of Canada-Clinical Trials Group. 2002
The Department of Medical Oncology and Hematology, Princess Margaret Hospital, 610 University Avenue, 5-104, Canada. 2001

References

The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. Shepherd, F.A., Crowley, J., Van Houtte, P., Postmus, P.E., Carney, D., Chansky, K., Shaikh, Z., Goldstraw, P. J. Thorac. Oncol (2007) [Pubmed]
Weighing tumor biology in treatment decisions for patients with non-small cell lung cancer. Shepherd, F.A., Rosell, R. J. Thorac. Oncol (2007) [Pubmed]
Angiogenesis inhibitors under study for the treatment of lung cancer. Shepherd, F.A., Sridhar, S.S. Lung. Cancer (2003) [Pubmed]
Second-line chemotherapy for non-small cell lung cancer. Shepherd, F.A. Expert. Rev. Anticancer. Ther (2003) [Pubmed]
Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. Shepherd, F.A., Giaccone, G., Seymour, L., Debruyne, C., Bezjak, A., Hirsh, V., Smylie, M., Rubin, S., Martins, H., Lamont, A., Krzakowski, M., Sadura, A., Zee, B. J. Clin. Oncol. (2002) [Pubmed]
Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group. Shepherd, F.A., Dancey, J., Arnold, A., Neville, A., Rusthoven, J., Johnson, R.D., Fisher, B., Eisenhauer, E. Cancer (2001) [Pubmed]
Chemotherapy for advanced non-small-cell lung cancer: modest progress, many choices. Shepherd, F.A. J. Clin. Oncol. (2000) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.